EVX1-AS

Across TCGA pan-cancer cohorts, EVX1-AS RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of EVX1-AS’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where EVX1-AS RNA is more highly expressed in tumor relative to normal tissue. In most cancer types EVX1-AS is over-expressed in tumor, although a few such as PRAD show the opposite, repressed pattern.

COAD, KIRC, and LUAD are the cancer types where EVX1-AS tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in EVX1-AS RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.798	<.001	6	view →
KIRC	All	All	+0.037	.012	3	view →
LUAD	All	All	+0.028	.014	3	view →
PRAD	All	All	−0.437	.001	2	view →
STAD	Male	All	+0.187	.016	2	view →
LIHC	Male	All	+0.049	.022	2	view →
CHOL	All	All	+0.745	.046	1	view →
LUSC	All	All	+0.068	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

EVX1-AS–COAD

Open the COAD breakdown →